The Trump administration has put in motion its plan to secure lower prescription drug costs for Americans. This week, the ...

Drugs being explicitly developed to treat rare diseases are getting more expensive. An analysis by Reuters found that prices ...

Entrepreneur Mark Cuban's Cost Plus ... A New RNA-Based Drug Startup Launches With Rutgers Science A Philadelphia-based biotech startup — by way of Rutgers University in New Jersey — has raised an ...

President Donald Trump's claim that prescription drug prices will be reduced “almost immediately" under a new executive order is misleading.

Trump’s executive order to cap U.S. costs risks limiting the supply of new pharmaceuticals. President Donald Trump’s ...

Economists begin by asking what would happen in a completely free market. Then we ask whether government intervention of some ...

SaveHealth explores the distinctions between brand-name and generic drugs, outlines the financial advantages of generic ...

Takeda is organized around five core businesses: oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for over 80% of revenue. It also has a developing ...

Experts said the president's executive order could work in lowering costs, but it won't make for an immediate fix.

Published studies have used periods ranging from 4 to 12 years ... The price of innovation: new estimates of drug development costs. J. Health Econ. 22, 151–185 (2003). Article Google Scholar ...

It’s also received a “Fast Track” designation from the FDA, which will speed up the drug development process. There’s also ongoing work on a potential HIV vaccine. To find out more about ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...